Charles Schwab Investment Management Inc Foghorn Therapeutics Inc. Transaction History
Charles Schwab Investment Management Inc
- $429 Billion
- Q1 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Foghorn Therapeutics Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 55,442 shares of FHTX stock, worth $318,791. This represents 0.0% of its overall portfolio holdings.
Number of Shares
55,442
Previous 55,442
-0.0%
Holding current value
$318,791
Previous $357,000
4.2%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding FHTX
# of Institutions
70Shares Held
23.6MCall Options Held
7.7KPut Options Held
1.4K-
Flagship Pioneering Inc. Cambridge, MA12.7MShares$72.9 Million5.6% of portfolio
-
Raymond James & Associates St Petersburg, FL2.23MShares$12.8 Million0.01% of portfolio
-
Euclidean Capital LLC New York, NY1.57MShares$9.05 Million1.36% of portfolio
-
Black Rock Inc. New York, NY1.32MShares$7.56 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.1MShares$6.34 Million0.0% of portfolio
About Foghorn Therapeutics Inc.
- Ticker FHTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,637,400
- Market Cap $239M
- Description
- Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-28...